Bridgewater, N.J. — Salix Pharmaceuticals, the gastroenterology division of Bausch Health Companies Inc. (NYSE/TSX: BHC), The U.S. Pain Foundation (USPF), and The International Foundation for Gastrointestinal Disorders (IFFGD) announced they… Read More
MISSISSAUGA, ON — AstraZeneca Canada, a leading innovation-driven biopharmaceutical company, has been named one of Greater Toronto’s Top Employers for the tenth straight year. The win comes on the heels of AstraZeneca’s… Read More
A dual JAK3/TEC inhibitor, LITFULO™ (ritlecitinib) is approved for adults and adolescents over 12 years of age for treatment of severe alopecia areata. KIRKLAND, QC, December 4, 2023 – Today,… Read More
The Research Approval Processes Project (RAPP) is set to make improvements to the operational approval application process for research studies. Operational Approval, also known as an Operational Review, holds a… Read More
The innovative pharmaceutical industry commends the ambition to address climate change as an urgent health challenge at COP28, including through the agreement of the first ever Declaration on Climate and… Read More
